Aegis Peptides KLOW 80mg Vial  4-in-1 Lyophilized Research Blend

Introducing the Aegis Peptides KLOW 80mg vial, a high-purity, multi-compound freeze-dried (lyophilized) peptide formulation supplied specifically for cellular repair, tissue remodeling, and inflammatory pathway research in the UK. Designed for custom laboratory reconstitution, this 80mg presentation provides high net active mass in a unified, multi-target research matrix.

What is the Aegis Peptides KLOW 80mg Vial?

The Aegis Peptides KLOW 80mg vial contains 80mg of total active peptide mass in a stable, freeze-dried cake format. Formulated as a synergistically balanced 4-in-1 research blend, the KLOW matrix combines four studied peptide sequences into a single vial, allowing laboratory technicians to reconstitute and evaluate complex co-administration protocols without managing multiple separate containers.

The 80mg KLOW multi-compound matrix consists of:

• GHK-Cu (50mg): Copper tripeptide evaluated for extracellular matrix remodeling, collagen stimulation, and cellular signaling.

• BPC-157 (10mg): Stable pentadecapeptide researched for tissue repair mechanisms, angiogenesis, and cell migration dynamics.

• TB-500 (10mg): Synthetic Thymosin Beta-4 sequence studied for actin sequestration, cell motility, and cytoskeletal dynamics.

• KPV (10mg): Alpha-MSH tripeptide fragment evaluated for targeted anti-inflammatory pathway modulation.

Why Choose the Aegis Peptides KLOW 80mg Research Vial?

Custom Reconstitution & Solvent Flexibility

Supplied as a freeze-dried lyophilized powder rather than a pre-mixed solution, the Aegis Peptides KLOW 80mg vial provides complete freedom over solvent selection. Laboratories can reconstitute the blend with sterile diluents (such as bacteriostatic water) to exact concentration parameters required by specific in-vitro or analytical protocols.

Streamlined Multi-Target Assay Protocols

Evaluating overlapping cellular pathways usually requires measuring, reconstituting, and combining four separate compounds. The KLOW 80mg vial simplifies assay preparation, reducing volumetric calculation errors and setup variability across repeated trials.

HPLC & Mass Spectrometry Verified (>99% Purity)

Every batch of the KLOW 80mg lyophilized powder UK range undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (LC-MS) testing to verify sequence identity and purity (>99%) for all four active components. Each order includes a lot-specific Certificate of Analysis (COA).

Express UK Cold-Chain Handling & Dispatch

When you buy KLOW 80mg vial UK stock from Aegis Peptides, your order is picked directly from climate-controlled UK storage facilities and shipped via express tracked couriers for rapid delivery and zero customs delays.

Aegis Peptides KLOW 80mg Formats: Vial vs. Pen

Feature	Aegis Peptides KLOW 80mg Vial	KLOW 80mg Pen
Physical Form	Lyophilized Powder (Freeze-Dried)	Pre-mixed Solution
Total Net Mass	80mg (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, 10mg KPV)	80mg (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, 10mg KPV)
Reconstitution	Required (Custom diluent volume)	Ready-to-use (No mixing needed)
Dosing Control	Variable molar concentration	Dial-a-dose applicator
Analytical Purity	>99% HPLC Verified	>99% HPLC Verified

Frequently Asked Questions About the Aegis Peptides KLOW 80mg Vial

How should unreconstituted KLOW 80mg vials be stored?

Unreconstituted lyophilized vials should be kept in a cool, dark, climate-controlled environment (below 4°C, or frozen at -20°C for long-term storage) to maintain structural integrity across all four active peptide sequences prior to reconstitution.

How can I buy the Aegis Peptides KLOW 80mg Vial in the UK?

You can order directly online through our secure shop portal. Visit our page to buy Aegis Peptides online UK for fast domestic UK dispatch and verified batch purity.